{"product_id":"epigenetic-cancer-therapy-9780323913676","title":"Epigenetic Cancer Therapy","description":"\u003cp\u003e\u003c\/p\u003e\u003cblockquote\u003eEpigenetic Cancer Therapy,Second Edition provides an updated discussion of epigenetic biology and therapeutics,including new discoveries and therapeutic programs. It highlights the role of epigenetics in cancer development and the potential of epigenetic therapies as a future management option. \u003c\/blockquote\u003e\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 772 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 03 May 2023\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Elsevier Science \u0026amp; Technology\u003cbr\u003e\u003c\/p\u003e \u003cp\u003e\u003cbr\u003eEpigenetic Cancer Therapy, Second Edition, is a comprehensive exploration of healthy and aberrant epigenetic biology, encompassing a wide range of topics. It delves into the latest discoveries aimed at enhancing our understanding of cancer epigenetics and therapeutics. The book encompasses significant intergovernmental initiatives and cutting-edge research across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. It serves as a valuable resource in elevating epigenetics as a promising therapeutic approach for managing cancer in the future.\u003cbr\u003e\u003cbr\u003eSince the first edition of this book was published, the field of epigenetics has witnessed remarkable advancements. New epigenetic therapies have been developed and approved for clinical use, expanding our understanding of the epigenome's plasticity in cancer and disease. There is growing evidence linking pollution to epigenetic alterations in cancer development, underscoring the importance of addressing these changes.\u003cbr\u003e\u003cbr\u003eTo reflect these developments, this second edition has been thoroughly revised and updated. It encompasses promising therapeutic programs such as CRISPR\/Cas9-mediated approaches, CAR-T-based therapies, epigenetic priming, histone modifications, and other transformative advancements in synthetic biology and cellular engineering.\u003cbr\u003e\u003cbr\u003eBy presenting a comprehensive and up-to-date account of epigenetic cancer therapy, Second Edition serves as a valuable resource for researchers, clinicians, and healthcare professionals alike. It provides a deeper understanding of epigenetic mechanisms and their implications in cancer development, paving the way for innovative and personalized treatment strategies.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWeight\u003c\/strong\u003e: 1536g\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 191 x 235 x 39 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9780323913676\u003cbr\u003e \u003cstrong\u003eEdition number\u003c\/strong\u003e: 2 ed\u003c\/p\u003e","brand":"Shulph Ink","offers":[{"title":"Paperback \/ softback","offer_id":44245196505338,"sku":"9780323913676","price":131.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/products\/1684492253923_book.jpg?v=1684527278","url":"https:\/\/shulphink.com\/products\/epigenetic-cancer-therapy-9780323913676","provider":"Shulph Ink","version":"1.0","type":"link"}